ISPOR Europe 2025
9 - 12 November
-
The Health Impact of Pembrolizumab in Combination With Chemotherapy for the First-Line Treatment of Patients With Squamous Metastatic Non-Small Cell Lung Cancer (mNSCLC) in Türkiye
Sep 9, 2025, 16:22 PM -
Data Linkage in Practice: A Living Systematic Review of Clinical Trials in the United States (US) Utilizing Linkage to Real-World Data
Sep 9, 2025, 16:22 PM -
Systematic Literature Review on the Burden and Economic Impact of Invasive Meningococcal Disease in Adolescents and Young Adults in France, Italy, Spain, and Germany
Sep 9, 2025, 16:22 PM -
Modeled Number and Cost of Biparametric Magnetic Resonance Imaging (bpMRI) Examinations in a Nationwide Prostate Cancer Screening Program: Utilizing the Results of the Czech Prostapilot Study
Sep 9, 2025, 16:22 PM -
Looking Back to Go Forward: Reintegrating Scientific Considerations Into eCOA Design and Implementation
Sep 9, 2025, 16:22 PM -
Dupilumab Improves Lung Function and Asthma Control While Reducing Systemic Corticosteroid Use in Patients With Allergic Bronchopulmonary Aspergillosis: The Phase 2 LIBERTY ABPA AIRED Study
Sep 9, 2025, 16:22 PM -
Early Change in Proteinuria as a Surrogate Endpoint in Studies of IgA Nephropathy: An Updated Patient-Level Meta-Analysis and Discussion of Appropriate Methodology
Sep 9, 2025, 16:22 PM -
A Transitional Reimbursement Mechanism for New Medicinal Products Addressing High Unmet Clinical Need in Greece: Proposal for a Medicines Innovation Fund
Sep 9, 2025, 16:22 PM -
Assessing the Value of the Enzyme Replacement Therapy for Hypophosphatasia (HPP): A Spanish Subanalysis of a Pan-European Multidisciplinary Multicriteria Decision Analysis (MCDA)
Sep 9, 2025, 16:22 PM -
Mapping the Rare Disease Diagnostic Odyssey of Today: An Adapted Targeted Literature Review (ATLR)
Sep 9, 2025, 16:22 PM -
Concordance Between Patient and Physician Reporting of Symptoms for Metastatic Urothelial Cancer in Europe: A Real-World Survey
Sep 9, 2025, 16:22 PM -
National Competent Authorities’ Experiences With Early Feasibility Study Assessment: Promoting Dialogue, Supporting Sponsors, and Fostering Shared Learning to Harmonize the EU Framework
Sep 9, 2025, 16:22 PM -
Innovative Drug Access in Portugal: An Analysis of Managed Entry Agreements Supporting Public Coverage 2014-2024
Sep 9, 2025, 16:22 PM -
Evaluating the Impact of International Drug Pricing Strategies on Indian State-Level
Sep 9, 2025, 16:22 PM -
Digital Twins: Hype or Hope for Better Health Outcomes
Sep 9, 2025, 16:22 PM -
Impact of Nonclinically Driven Inhaler Initiation or Switch on Carbon (CO2) Emissions and Healthcare Costs for COPD Patients Using Single-Inhaler Triple Therapy (SITT)
Sep 9, 2025, 16:22 PM -
German Early Benefit Assessments and the Impact of Medical Societies: An Analysis
Sep 9, 2025, 16:22 PM -
Advancing Real-World Evidence in Diffuse Large B-cell Lymphoma: Insights From EHR-Derived Data in the UK
Sep 9, 2025, 16:22 PM -
The Association Between Average Sales Price Decline and Shortages in Small Molecule Injectable Oncology Therapies With Generic Competition
Sep 9, 2025, 16:22 PM -
ESMO-MCBS Evaluation and French Derogatory Access Decision: Is There a Correlation?
Sep 9, 2025, 16:22 PM